REMSleep Holdings Inc
REMSleep Holdings, Inc. focuses on the development and distribution of products to help people affected by sleep apnea worldwide. The company offers DeltaWave CPAP interface device to treat patients with sleep apnea. It serves sleep product distributors, home care dealers, private sleep labs, product end users, sleep physicians, medical group, and hospitals, as well as medical associations. The c… Read more
REMSleep Holdings Inc (RMSL) - Net Assets
Latest net assets as of June 2024: $572.52K USD
Based on the latest financial reports, REMSleep Holdings Inc (RMSL) has net assets worth $572.52K USD as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.07 Million) and total liabilities ($493.90K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $572.52K |
| % of Total Assets | 53.69% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 2855.87 |
REMSleep Holdings Inc - Net Assets Trend (2007–2023)
This chart illustrates how REMSleep Holdings Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for REMSleep Holdings Inc (2007–2023)
The table below shows the annual net assets of REMSleep Holdings Inc from 2007 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $930.70K | -65.64% |
| 2022-12-31 | $2.71 Million | +3.43% |
| 2021-12-31 | $2.62 Million | +400.82% |
| 2020-12-31 | $-870.50K | +13.80% |
| 2019-12-31 | $-1.01 Million | -74.08% |
| 2018-12-31 | $-580.09K | -16.59% |
| 2017-12-31 | $-497.55K | -68.80% |
| 2016-12-31 | $-294.75K | +91.35% |
| 2015-12-31 | $-3.41 Million | +35.38% |
| 2014-12-31 | $-5.28 Million | -638.44% |
| 2012-12-31 | $-714.42K | -6789.99% |
| 2010-12-31 | $10.68K | +154.05% |
| 2009-12-31 | $-19.76K | -584.48% |
| 2008-12-31 | $4.08K | +245.80% |
| 2007-12-31 | $-2.80K | -- |
Equity Component Analysis
This analysis shows how different components contribute to REMSleep Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1415496200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $15.12 Million | 1624.96% |
| Total Equity | $930.70K | 100.00% |
REMSleep Holdings Inc Competitors by Market Cap
The table below lists competitors of REMSleep Holdings Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Ryvyl Inc
NASDAQ:RVYL
|
$10.33 Million |
|
Bcal Diagnostics Ltd
AU:BDX
|
$10.33 Million |
|
Jindo.Co. Ltd
KO:088790
|
$10.33 Million |
|
Minesto AB
ST:MINEST
|
$10.33 Million |
|
Koroplast Temizlik Ambalaj Urunleri San. ve Dis Ticaret A.S.
IS:KRPLS
|
$10.32 Million |
|
Vinalink International Freight Forwarders
VN:VNL
|
$10.32 Million |
|
Pintaras Jaya Bhd
KLSE:9598
|
$10.32 Million |
|
PT Homeco Victoria Makmur Tbk
JK:LIVE
|
$10.31 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in REMSleep Holdings Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 2,708,538 to 930,700, a change of -1,777,838 (-65.6%).
- Net loss of 1,777,838 reduced equity.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.78 Million | -191.02% |
| Total Change | $- | -65.64% |
Book Value vs Market Value Analysis
This analysis compares REMSleep Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 14.45x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-12-31 | $-2.54 | $0.01 | x |
| 2008-12-31 | $64.73 | $0.01 | x |
| 2009-12-31 | $-299.35 | $0.01 | x |
| 2010-12-31 | $5.14 | $0.01 | x |
| 2011-12-31 | $2.80 | $0.01 | x |
| 2012-12-31 | $-89.26 | $0.01 | x |
| 2014-12-31 | $-403.08 | $0.01 | x |
| 2015-12-31 | $-1.13 | $0.01 | x |
| 2016-12-31 | $-0.10 | $0.01 | x |
| 2017-12-31 | $-0.15 | $0.01 | x |
| 2018-12-31 | $-0.14 | $0.01 | x |
| 2019-12-31 | $-0.02 | $0.01 | x |
| 2020-12-31 | $0.00 | $0.01 | x |
| 2021-12-31 | $0.00 | $0.01 | x |
| 2022-12-31 | $0.00 | $0.01 | x |
| 2023-12-31 | $0.00 | $0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently REMSleep Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -191.02%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -872.70%
- • Asset Turnover: 0.17x
- • Equity Multiplier: 1.30x
- Recent ROE (-191.02%) is above the historical average (-76076.35%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | 0.00% | 0.00% | 0.00x | 0.00x | $-37.52K |
| 2008 | -811.06% | 0.00% | 0.00x | 2.08x | $-33.48K |
| 2009 | 0.00% | 0.00% | 0.00x | 0.00x | $-21.86K |
| 2010 | -1062159.90% | 0.00% | 0.00x | 1.01x | $-113.43 Million |
| 2011 | -153822.40% | 0.00% | 0.00x | 1.00x | $-19.01 Million |
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $-17.43 Million |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.41 Million |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-108.69K |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-56.90K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-604.21K |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-354.69K |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-4.18 Million |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.70 Million |
| 2021 | -181.17% | -3964.45% | 0.03x | 1.34x | $-5.01 Million |
| 2022 | -56.04% | -473.28% | 0.10x | 1.24x | $-1.79 Million |
| 2023 | -191.02% | -872.70% | 0.17x | 1.30x | $-1.87 Million |
Industry Comparison
This section compares REMSleep Holdings Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| REMSleep Holdings Inc (RMSL) | $572.52K | 0.00% | 0.86x | $10.32 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |